Triple-therapy breakthrough halts pancreatic tumors in mice
TL;DR
Spanish CNIO researchers report that a triple combination therapy—an experimental KRAS inhibitor, an existing lung-cancer drug, and a protein degrader—caused long-lasting regression and prevented recurrence of pancreatic ductal adenocarcinoma in three mouse models, a potential path toward new clinical trials, though optimization for patients and trials is not yet planned.
- Scientists achieve pancreatic tumour regression in breakthrough study Euronews.com
- Spanish scientist finds cure for pancreatic cancer in major medical breakthrough Times of India
- Pancreatic cancer, an announcement from Spain: "Tumor eliminated in mice" lamilano.it
- Spanish scientists achieve complete eradication of pancreatic cancer thanks to combination of 3 drugs Gamereactor UK
- Who Is Dr. Mariano Barbacid? Spanish Scientist Leading The Most Promising Pancreatic Cancer Breakthrough Yet Times Now
Want the full story? Read the original reporting
Read on Euronews.com